mhurhangee/ep-ind-claims huggingface dataset:
A vacuum pump, in particular a turbomolecular pump, having a pump inlet, a pump outlet and a pump space for a gas to be pumped arranged between the pump inlet and the pump outlet, as well as having at least one cooling gas inlet for a cooling gas for cooling the vacuum pump and having at least two hollow regions (50, 52, 54) for the cooling gas connected in a gas conducting manner to the cooling gas inlet and arranged outside the pump space, characterized in that the hollow regions (50, 52, 54) are arranged in a heat conducting lower part of the vacuum pump, wherein the hollow regions (50, 52, 54) are each formed as a passage; and wherein at least two passages (50, 52, 54) are provided which extend in different directions about an axis of rotation of the vacuum pump.
Method for monitoring the health condition of a rotor of a wind energy plant, said method comprising the steps of: measuring activity signals of the blades in said rotor, establishing differential values between the activity signals of different blades, and characterised in that the differential values are used for monitoring the health condition of the rotor in the wind energy plant. measuring activity signals of the blades in said rotor, establishing differential values between the activity signals of different blades, and characterised in that the differential values are used for monitoring the health condition of the rotor in the wind energy plant.
An intermediate compound for preparation of a photochromic compound, wherein said intermediate compound is represented by the following Formula (I-A), wherein, Ring-A is selected from aryl and fused ring aryl, n is selected from 1 to 8, R 1 for each n is in each case independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl, halogen; cyano; -O-R10' or -S-R10', wherein each R10' is independently selected from hydrogen, hydrocarbyl or substituted hydrocarbyl; and -N(R11')R12', wherein R11' and R12' are each independently selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, or R11' and R12' together form a ring structure optionally including at least one heteroatom, R 2 and R 3 are each independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, halogen, -N(R 14)(R 15), - SR 16, and -OR16, where R 14 and R 15 are each independently selected from hydrogen, hydrocarbyl, and substituted hydrocarbyl, or R 14 and R 15 together form a ring, and each R 16 is independently selected from hydrocarbyl and substituted hydrocarbyl, R 4 and R 5 are each independently selected from hydrogen, hydrocarbyl, and substituted hydrocarbyl, R 6 is selected from hydrogen, -C -R 19 and -S R 19, wherein R 19 is selected from hydrocarbyl and halohydrocarbyl, Z 1 and Z 3 are each independently selected from O, C and C(R a)(R b), where R a and R b are each independently selected from hydrogen, hydroxyl, and C 1 -C 20 linear or branched alkyl, provided that at least one of Z 1 and Z 3 is C, and Z 2 is selected from O, S, and N-R 13, where R 13 is selected from hydrogen, hydrocarbyl and substituted hydrocarbyl. Ring-A is selected from aryl and fused ring aryl, n is selected from 1 to 8, R 1 for each n is in each case independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl, halogen; cyano; -O-R10' or -S-R10', wherein each R10' is independently selected from hydrogen, hydrocarbyl or substituted hydrocarbyl; and -N(R11')R12', wherein R11' and R12' are each independently selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, or R11' and R12' together form a ring structure optionally including at least one heteroatom, R 2 and R 3 are each independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, halogen, -N(R 14)(R 15), - SR 16, and -OR16, where R 14 and R 15 are each independently selected from hydrogen, hydrocarbyl, and substituted hydrocarbyl, or R 14 and R 15 together form a ring, and each R 16 is independently selected from hydrocarbyl and substituted hydrocarbyl, R 4 and R 5 are each independently selected from hydrogen, hydrocarbyl, and substituted hydrocarbyl, R 6 is selected from hydrogen, -C -R 19 and -S R 19, wherein R 19 is selected from hydrocarbyl and halohydrocarbyl, Z 1 and Z 3 are each independently selected from O, C and C(R a)(R b), where R a and R b are each independently selected from hydrogen, hydroxyl, and C 1 -C 20 linear or branched alkyl, provided that at least one of Z 1 and Z 3 is C, and Z 2 is selected from O, S, and N-R 13, where R 13 is selected from hydrogen, hydrocarbyl and substituted hydrocarbyl.
A method for establishing a secondary cell group, SCG, split bearer in a dual connectivity between different radio access technologies, RATs, in a wireless communication system, the method performed by a primary base station supporting a first RAT comprising: transmitting, to a secondary base station supporting a second RAT, a first message for requesting addition of the secondary base station, wherein the first message includes a first parameter about quality of service, QoS, which is a full quality requirement parameter received from a core network of the first RAT, and a second parameter associated with guaranteed bit rate QoS, GBR QoS, that is admittable by master cell group, MCG; and receiving, from the secondary base station, a second message, wherein the second message includes a third parameter about QoS to be provided by the MCG, wherein the first RAT is 4 th generation, 4G, long term evolution, LTE, and the second RAT is 5 th generation, 5G, new radio, NR transmitting, to a secondary base station supporting a second RAT, a first message for requesting addition of the secondary base station, wherein the first message includes a first parameter about quality of service, QoS, which is a full quality requirement parameter received from a core network of the first RAT, and a second parameter associated with guaranteed bit rate QoS, GBR QoS, that is admittable by master cell group, MCG; and receiving, from the secondary base station, a second message, wherein the second message includes a third parameter about QoS to be provided by the MCG, wherein the first RAT is 4 th generation, 4G, long term evolution, LTE, and the second RAT is 5 th generation, 5G, new radio, NR
A liquid repellent compound represented by the following formula: wherein Cf is a C 1-20 fluoroalkyl group or a C 1-20 fluoroalkyl group having an etheric oxygen atom between carbon atoms, each of R 1 and R 2 which are independent of each other, is a hydrogen atom, a C 1-6 alkyl group or a phenyl group, X is an oxygen atom, a sulfur atom, a nitrogen atom or NH, n is an integer of from 0 to 4, m is 1 when X is an oxygen atom, a sulfur atom or NH, or 2 when X is a nitrogen atom, Z is R 4 R 5 C=CR 3 -CO-, and each of R 3, R 4 and R 5 which are independent of one another, is a hydrogen atom or a methyl group. each of R 1 and R 2 which are independent of each other, is a hydrogen atom, a C 1-6 alkyl group or a phenyl group, X is an oxygen atom, a sulfur atom, a nitrogen atom or NH, n is an integer of from 0 to 4, m is 1 when X is an oxygen atom, a sulfur atom or NH, or 2 when X is a nitrogen atom, Z is R 4 R 5 C=CR 3 -CO-, and each of R 3, R 4 and R 5 which are independent of one another, is a hydrogen atom or a methyl group.
Automatic apparatus suitable for the withdrawal of portions of biological material from a parent test tube, mobile in a conveyor of a test tube transport plant by means of transport devices of single test tubes, to be loaded in one or more children test tubes countermarked beforehand with suitable identification means and to be sent to different biological material analysis instruments interfaced to said transport plant, said apparatus comprising a work bench which provides a first lane joined to the conveyor and provided with a first stop point for queued children test tubes supported in the transport devices, a second lane joined to the conveyor and provided with a second stop point for queued parent test tubes supported in the transport devices, a diversion passing from the first lane after the first stop point to the second lane after the second stop point, a work point on the second lane down the second stop point, presence sensors positioned on the second lane to control the presence and number of tubes queued in the work point,a device suitable for the withdrawal and distribution of portions of biological material from the parent test tube to the respective children test tubes queued to the parent test tube at the work point of the work bench, a device suitable for presenting pipettes, a return third lane going back from the work point to the conveyor, a control unit configured to coordinate and check the devices involved in the work cycle of the work bench so as to release a parent test tube from the second stop point to reach the work point on the second lane, release a predefined number of children test tubes which are queued after the parent test tube behind the work point, control the actual presence of the expected number of children test tubes queued after the parent test tube in the work point, withdraw portions of biological materials from the parent test tube, distribute said portions in children test tubes and return the transport devices with the parent test tube and the children test tubes filled with aliquots or portions of the biological material contained in the parent test tube by the return third lane to the conveyor.
Elafibranor, or a pharmaceutically acceptable salt thereof, for administration at a dose varying between 1 mg and 150 mg per administration, for use for the treatment of Primary Biliary Cholangitis.
A method of purifying at least one acidic protein of interest from a protein preparation containing impurities, comprising: (a) applying an equilibration buffer comprising CaCl 2 to hydroxyapatite resin; (b) contacting the hydroxyapatite resin with the protein preparation in a load buffer; (c) washing the hydroxyapatite resin with a wash buffer comprising CaCl 2; and (d) eluting at least one acidic protein from the hydroxyapatite resin with an elution buffer comprising 2 to 50 mM phosphate. (a) applying an equilibration buffer comprising CaCl 2 to hydroxyapatite resin; (b) contacting the hydroxyapatite resin with the protein preparation in a load buffer; (c) washing the hydroxyapatite resin with a wash buffer comprising CaCl 2; and (d) eluting at least one acidic protein from the hydroxyapatite resin with an elution buffer comprising 2 to 50 mM phosphate.
An apparatus for producing cores of a fat-containing confectionery mass, comprising a cooled moulding apparatus for moulding the cores, the moulding apparatus including two moulding rollers (23, 24) being driven in opposite directions and including a multitude of impressions into which the liquid confectionery mass can flow to form the cores and to solidify there, characterised by a separate cooling apparatus including a cooling roller, the cooling apparatus being arranged upstream of the moulding apparatus.
A dispenser head (400; 700; 100) for dispensing a unit (C; P) of a pharmaceutical drug or a food supplement or food, said dispenser head (400; 700; 100) comprising: a dosing duct (402; 702; 102) extending along a dosing axis (404; 704; 104) and connecting an inlet port (406; 706; 106) for receiving the unit (C; P) from a reservoir (41, 71, 11) with an exit port (408; 708; 108) for dispensing the unit (C; P); a support section (430; 730; 130) for the unit (C; P), which extends from the exit port (408; 708; 108) parallel to the dosing axis (404; 704; 104); and a retention section (410; 710; 110), which extends from the support section (430; 730; 130), characterized in that two opposing, U-shaped access openings are provided by at least the support section (430; 730; 130), by the retention section (410; 710; 110) and by the exit port (408; 708; 108) so that the unit (C; P) can be removed with index finger and thumb. a dosing duct (402; 702; 102) extending along a dosing axis (404; 704; 104) and connecting an inlet port (406; 706; 106) for receiving the unit (C; P) from a reservoir (41, 71, 11) with an exit port (408; 708; 108) for dispensing the unit (C; P); a support section (430; 730; 130) for the unit (C; P), which extends from the exit port (408; 708; 108) parallel to the dosing axis (404; 704; 104); and a retention section (410; 710; 110), which extends from the support section (430; 730; 130), characterized in that two opposing, U-shaped access openings are provided by at least the support section (430; 730; 130), by the retention section (410; 710; 110) and by the exit port (408; 708; 108) so that the unit (C; P) can be removed with index finger and thumb.
A folding front-loading bicycle of the type comprising a loading surface in its front part, with the axle of the front steering wheel being moved forward to leave space for said surface and incorporating an indirect steering system, characterized by comprising at least one folding system for folding its front wheel onto a main frame by means of a front swingarm with the loading surface in which said front wheel is incorporated around a front rotating shaft such that, in the folded position, the front wheel is superimposed on the main frame and the loading surface is located below the main frame acting as a support surface on which the entire bicycle rests in its folded position.
Gastro-resistant vector suitable for oral administration of at least one pharmaceutical and/or antigenic active substance comprising an aqueous phase and an oily phase in the form of an emulsion of water-in-oil (W/O) type in which the aqueous phase comprises at least one active ingredient and from 2% to 40% by weight of hydrophilic polymer that is insoluble in an aqueous phase at pH < 6.5, and in which the oily phase comprises at least one surfactant and at least one oil consisting of ethyl oleate.
Photovoltaic component having a lower electrode applied to a substrate, a semiconducting photovoltaically active layer characterised by an upper electrode thereon comprising conductive organic material, which is the positive electrode, in which the lower electrode is semitransparent, and the upper electrode is opaque.
Propulsion machine for a body of water having a drive housing, wherein the drive housing is mounted in an azimuthally rotatable manner by means of an azimuth bearing having at least one magnetic bearing (62, 69, 70), wherein the azimuth bearing has an axial bearing (62, 65, 66) and a radial bearing (63, 69, 70, 71), wherein the axial bearing (62, 65, 66) is tshe magnetic bearing and/or wherein the radial bearing (63, 69, 70, 71) is the magnetic bearing (69, 70), wherein a spacing element spaces the axial bearing (62, 65, 66) apart from the radial bearing (63, 69, 70, 71), wherein the spacing element insulates electrically.
A computer system, comprising: a processor; a display device coupled to the processor; and memory coupled to the processor and comprising instructions that, when executed, cause the processor to perform a method used for planning radiation treatment, the method comprising: accessing information comprising a location of an isocenter that is based on a location of a treatment target; accessing information comprising a value of beam energy for a beam of radiation and also comprising a value of an angle of the beam relative to the treatment target; determining a range of a field of the beam relative to the treatment target using the isocenter and the angle; determining whether the range satisfies a criterion; and when the criterion is satisfied, including the value of the angle of the beam in a plan for the radiation treatment. a processor; a display device coupled to the processor; and memory coupled to the processor and comprising instructions that, when executed, cause the processor to perform a method used for planning radiation treatment, the method comprising: accessing information comprising a location of an isocenter that is based on a location of a treatment target; accessing information comprising a value of beam energy for a beam of radiation and also comprising a value of an angle of the beam relative to the treatment target; determining a range of a field of the beam relative to the treatment target using the isocenter and the angle; determining whether the range satisfies a criterion; and when the criterion is satisfied, including the value of the angle of the beam in a plan for the radiation treatment. accessing information comprising a location of an isocenter that is based on a location of a treatment target; accessing information comprising a value of beam energy for a beam of radiation and also comprising a value of an angle of the beam relative to the treatment target; determining a range of a field of the beam relative to the treatment target using the isocenter and the angle; determining whether the range satisfies a criterion; and when the criterion is satisfied, including the value of the angle of the beam in a plan for the radiation treatment.
A refrigeration unit comprising: an evaporator; defrost means for defrosting said evaporator; and at least one temperature sensor in measurable connection with said evaporator; wherein at least one controller is communicatively connected to said at least one temperature sensor, wherein said at least one controller is configured to begin calculating a rate of temperature rise when the temperature reaches approximately the freezing point of water and to terminate operation of said defrost means when said rate exhibits a predetermined criteria; wherein said at least one controller is further configured to determine a point in time at which said temperature has risen to a freezing point of water; and characterized in that said predetermined criteria is the absence of any significant or detectable change of the rate of temperature rise after a specified length of time starting at said point in time. an evaporator; defrost means for defrosting said evaporator; and at least one temperature sensor in measurable connection with said evaporator; wherein at least one controller is communicatively connected to said at least one temperature sensor, wherein said at least one controller is configured to begin calculating a rate of temperature rise when the temperature reaches approximately the freezing point of water and to terminate operation of said defrost means when said rate exhibits a predetermined criteria; wherein said at least one controller is further configured to determine a point in time at which said temperature has risen to a freezing point of water; and characterized in that said predetermined criteria is the absence of any significant or detectable change of the rate of temperature rise after a specified length of time starting at said point in time.
A method for generating a deglycosylated polypeptide of interest, comprising: producing a plant cell that comprises: (a) a first nucleic acid comprising a first nucleotide sequence encoding a bacterial PNGase F polypeptide, wherein the first nucleotide sequence is operably linked to a promoter such that when the promoter is activated, the PNGase F polypeptide is transiently expressed; and (b) a second nucleic acid comprising a nucleotide sequence encoding the polypeptide of interest, wherein the second nucleotide sequence is operably linked to a promoter such that when the promoter is activated, the polypeptide of interest is expressed, and wherein the polypeptide of interest contains a glycosylation site, wherein the PNGase F polypeptide and the polypeptide of interest include a signal secretion sequence, and wherein by action of the PNGase F polypeptide, the polypeptide of interest is deglycosylated. producing a plant cell that comprises: (a) a first nucleic acid comprising a first nucleotide sequence encoding a bacterial PNGase F polypeptide, wherein the first nucleotide sequence is operably linked to a promoter such that when the promoter is activated, the PNGase F polypeptide is transiently expressed; and (b) a second nucleic acid comprising a nucleotide sequence encoding the polypeptide of interest, wherein the second nucleotide sequence is operably linked to a promoter such that when the promoter is activated, the polypeptide of interest is expressed, and wherein the polypeptide of interest contains a glycosylation site, (a) a first nucleic acid comprising a first nucleotide sequence encoding a bacterial PNGase F polypeptide, wherein the first nucleotide sequence is operably linked to a promoter such that when the promoter is activated, the PNGase F polypeptide is transiently expressed; and (b) a second nucleic acid comprising a nucleotide sequence encoding the polypeptide of interest, wherein the second nucleotide sequence is operably linked to a promoter such that when the promoter is activated, the polypeptide of interest is expressed, and wherein the polypeptide of interest contains a glycosylation site, wherein the PNGase F polypeptide and the polypeptide of interest include a signal secretion sequence, and wherein by action of the PNGase F polypeptide, the polypeptide of interest is deglycosylated.
A system for forming wafer blocks, said wafer blocks comprising at least three wafer sheets and at least two cream layers consisting of two different creams, the wafer sheets and the cream layers being arranged alternately and lying in parallel on top of one another, comprising: - an input station at which individual wafer sheets, preferably coming from a wafer-baking machine, are transferred successively to the system, - a first conveying surface for transporting first wafer sheets, there being along the first conveying surface a first spreading station for applying a first cream layer consisting of a first cream to the first wafer sheets, - a second conveying surface for transporting second wafer sheets, there being along the second conveying surface a second spreading station for applying a second cream layer consisting of a second cream to the second wafer sheets, - a third conveying surface for transporting third wafer sheets, - a stacking station at which the first wafer sheets with their first cream layers, the second wafer sheets with their second cream layers, and the third wafer sheets are stacked to form one or more wafer blocks, - an input distribution guide assembly via which the wafer sheets from the input station are transferred either to the first conveying surface, to the second conveying surface or to the third conveying surface, characterised in that the system comprises an output distribution guide assembly via which the wafer sheets either from the first conveying surface, from the second conveying surface or from the third conveying surface are transferred to the stacking station. - an input station at which individual wafer sheets, preferably coming from a wafer-baking machine, are transferred successively to the system, - a first conveying surface for transporting first wafer sheets, there being along the first conveying surface a first spreading station for applying a first cream layer consisting of a first cream to the first wafer sheets, - a second conveying surface for transporting second wafer sheets, there being along the second conveying surface a second spreading station for applying a second cream layer consisting of a second cream to the second wafer sheets, - a third conveying surface for transporting third wafer sheets, - a stacking station at which the first wafer sheets with their first cream layers, the second wafer sheets with their second cream layers, and the third wafer sheets are stacked to form one or more wafer blocks, - an input distribution guide assembly via which the wafer sheets from the input station are transferred either to the first conveying surface, to the second conveying surface or to the third conveying surface,